![Wade Hull](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Wade Hull
Director Técnico/Científico/I+D en CRESCITA THERAPEUTICS INC. .
Fortuna: 12 563 $ al 31/05/2024
Cargos activos de Wade Hull
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CRESCITA THERAPEUTICS INC. | Director Técnico/Científico/I+D | 01/03/2016 | - |
Historial de carrera de Wade Hull
Antiguos cargos conocidos de Wade Hull.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
UTAH MEDICAL PRODUCTS, INC. | Corporate Officer/Principal | 01/05/1996 | 01/12/1996 |
NUVO PHARMACEUTICALS INC. | Director Técnico/Científico/I+D | - | - |
ZARS Pharma, Inc.
![]() ZARS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZARS Pharma, Inc. develops and distributes drugs. It is a specialty pharmaceutical company focused on the development and commercialization of topically administered drugs, primarily for the treatment of pain, using its proprietary drug delivery technologies. The company was founded by Jie Zhang, Theodore H. Stanley, Larry D. Rigby and Michael A. Ashburn in 1996 and is headquartered in Salt Lake City, UT. | Director Técnico/Científico/I+D | 01/08/1998 | - |
Formación de Wade Hull.
University of Utah | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 4 |
Canadá | 3 |
Operativa
Chief Tech/Sci/R&D Officer | 3 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
UTAH MEDICAL PRODUCTS, INC. | Health Technology |
CRESCITA THERAPEUTICS INC. | Health Technology |
Empresas privadas | 2 |
---|---|
ZARS Pharma, Inc.
![]() ZARS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZARS Pharma, Inc. develops and distributes drugs. It is a specialty pharmaceutical company focused on the development and commercialization of topically administered drugs, primarily for the treatment of pain, using its proprietary drug delivery technologies. The company was founded by Jie Zhang, Theodore H. Stanley, Larry D. Rigby and Michael A. Ashburn in 1996 and is headquartered in Salt Lake City, UT. | Health Technology |
Nuvo Pharmaceuticals, Inc.
![]() Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Wade Hull
- Experiencia